IL6 and neoplasm: Cancerous cells release IL-6 within the ovarian cancer microenvironment, resulting in limitation of dendritic cell maturation and promoting immunosuppressive classically activated tumor-associated macrophages (TAMs), compromising the stimulation of tumor-infiltrating T cells.